Baxter International, Inc. (BAX)
25.79
+0.14
(+0.55%)
USD |
NYSE |
Nov 06, 16:00
25.75
-0.04
(-0.16%)
Pre-Market: 20:00
Baxter International Cash from Investing (Quarterly) : -110.00M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -110.00M |
| June 30, 2026 | -117.00M |
| March 31, 2026 | -133.00M |
| December 31, 2025 | -198.00M |
| September 30, 2025 | -111.00M |
| June 30, 2025 | -115.00M |
| March 31, 2025 | 3.265B |
| December 31, 2024 | -205.00M |
| September 30, 2024 | -164.00M |
| June 30, 2024 | -91.00M |
| March 31, 2024 | -166.00M |
| December 31, 2023 | -230.00M |
| September 30, 2023 | 3.786B |
| June 30, 2023 | -173.00M |
| March 31, 2023 | -170.00M |
| December 31, 2022 | -256.00M |
| September 30, 2022 | -184.00M |
| June 30, 2022 | -187.00M |
| March 31, 2022 | -304.00M |
| December 31, 2021 | -10.27B |
| September 30, 2021 | -207.00M |
| June 30, 2021 | -188.00M |
| March 31, 2021 | -538.00M |
| December 31, 2020 | -264.00M |
| September 30, 2020 | -157.00M |
| Date | Value |
|---|---|
| June 30, 2020 | -154.00M |
| March 31, 2020 | -604.00M |
| December 31, 2019 | -421.00M |
| September 30, 2019 | -231.00M |
| June 30, 2019 | -147.00M |
| March 31, 2019 | -301.00M |
| December 31, 2018 | -216.00M |
| September 30, 2018 | -161.00M |
| June 30, 2018 | -165.00M |
| March 31, 2018 | -374.00M |
| December 31, 2017 | -222.00M |
| September 30, 2017 | -775.00M |
| June 30, 2017 | -196.00M |
| March 31, 2017 | -117.00M |
| December 31, 2016 | -179.00M |
| September 30, 2016 | -166.00M |
| June 30, 2016 | -169.00M |
| March 31, 2016 | -201.00M |
| December 31, 2015 | -232.00M |
| September 30, 2015 | -215.00M |
| June 30, 2015 | -590.00M |
| March 31, 2015 | -770.00M |
| December 31, 2014 | 3.00M |
| September 30, 2014 | -619.00M |
| June 30, 2014 | -542.00M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Becton, Dickinson & Co. | -- |
| Boston Scientific Corp. | -437.00M |
| DexCom, Inc. | -76.70M |
| Abbott Laboratories | -385.00M |
| ICU Medical, Inc. | -20.14M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 558.00M |
| Cash from Financing (Quarterly) | -620.00M |
| Free Cash Flow | 1.134B |
| Free Cash Flow Per Share (Quarterly) | 0.8615 |
| Free Cash Flow to Equity (Quarterly) | 1.293B |
| Free Cash Flow to Firm (Quarterly) | 500.17M |
| Free Cash Flow Yield | 8.51% |